<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02270749</url>
  </required_header>
  <id_info>
    <org_study_id>VITAALII</org_study_id>
    <nct_id>NCT02270749</nct_id>
  </id_info>
  <brief_title>Vitamin Deficiencies and Suppletion in Morbid Obesity</brief_title>
  <official_title>Vitamin Deficiencies and Suppletion in Morbid Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the most effective treatment for patients who
      underwent a Roux-en-Y gastric bypass and developed postoperatively a vitamin B12 deficiency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin B12 deficiency accounts up to 23-64% bariatric surgery. The investigators purpose is
      to evaluate the most effective treatment for vitamin B12 deficiency in patients who underwent
      a Roux-en-Y gastric bypass.

      Daily oral use of vitamin B12 tablets are may be as effective as vitamin B12 injections.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction in patients with vitamin B12 deficiency</measure>
    <time_frame>6 months after initiating therapy</time_frame>
    <description>Before starting treatment vitamin B12, homocystein and methylmalonic acid will be measured. Two and 4 months after starting treatment vitamine B12 levels will be measured. At 6 months after initiating therapy again vitamin B12, homocystein and methylmalonic acid will be measured.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Vitamin B12 Deficiency</condition>
  <arm_group>
    <arm_group_label>hydroxocobalamin injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 patients receive the standard treatment of a vitamin B12 deficiency: hydroxocobalamin injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FitForMe vitamin B12 tablets</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 patients receive a daily dose vitamine B12 tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxocobalamin</intervention_name>
    <description>patients are treated for 6 months with hydroxocobalamin. Patients will be treated with once a dose of 2000ug, after that treatment will be continued with a dose of 1000ug per 2 months. At timepoint 0, 2, 4 and 6 months after treatment vitamin B12 will be measured. At timepoint 0 and 6 also homocystein and methylmalonic acid will be measured.</description>
    <arm_group_label>hydroxocobalamin injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>FitForMe vitamin B12</intervention_name>
    <description>patients are treated for 6 months with a daily dose of 1000ug vitamin B12 tablets. At timepoint 0, 2, 4 and 6 months after treatment vitamin B12 will be measured. At timepoint 0 and 6 also homocystein and methylmalonic acid will be measured.</description>
    <arm_group_label>FitForMe vitamin B12 tablets</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Vitamin B12 deficiency: &lt;200 pmol/l

          -  Vitamin B12 deficiency 6-12 months after surgery

          -  All patients underwent a Roux-en-Y gastric bypass

        Exclusion Criteria:

          1. Creatin &gt;150micromol/L

          2. Liver enzymes &gt;2 times upper limit

          3. Other bariatric operations

          4. Intercurrent diseases

          5. Gastro-intestinal diseases

          6. Psychiatric disease

          7. Medicines which influences bone density

          8. Pregnancy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rijnstate hospital</name>
      <address>
        <city>Arnhem</city>
        <zip>6800WC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Schijns, MD</last_name>
      <phone>0031880057353</phone>
      <email>wschijns@rijnstate.nl</email>
    </contact>
    <investigator>
      <last_name>Frits Berends, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wendy Schijns, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2014</study_first_submitted>
  <study_first_submitted_qc>October 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2014</study_first_posted>
  <last_update_submitted>May 6, 2015</last_update_submitted>
  <last_update_submitted_qc>May 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Vitamin B 12 Deficiency</mesh_term>
    <mesh_term>Avitaminosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

